⌘K
Loading ticker…
Jazz Pharmaceuticals, Inc. · Healthcare · Pharmaceutical Products
As of 2026-06-26, Jazz Pharmaceuticals, Inc. (JAZZ) has a 3-month relative strength percentile of 73 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 66. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 3.0%, relative volume 0.87×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 73, Market Stance is mixed at 47, A/D rating B
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
JAZZ is in a stage 2 uptrend, week 12. Currently in a 15-day base; basing ADR 2.9% (broad 2.6%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: 3.0% / 29.6%.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
JAZZ is held by 6 ETFs as of Mar 2026. Top owner: VTI at 0.02% weight, $351M notional. Top 3 carry $768M.
Top 6 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.02% | $351M |
| VBVanguard Small Cap ETF | 0.15% | $255M |
| VBRVanguard Small Cap Value ETF | 0.27% | $162M |
| VXFVanguard Extended Market ETF | 0.16% | $128M |
| IWDiShares Russell 1000 Value ETF | 0.04% | $25M |
| IWBiShares Russell 1000 ETF | 0.02% | $8M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JAZZ Jan avg: -1.03% median: -0.95% win: 25% σ: 1.83% n: 4 2022-04-12 → 2026-05-29 | JAZZ Feb avg: 4.36% median: 6.15% win: 50% σ: 13.16% n: 4 2022-04-12 → 2026-05-29 | JAZZ Mar avg: -2.13% median: 0.38% win: 50% σ: 7.83% n: 4 2022-04-12 → 2026-05-29 | JAZZ Apr avg: -2.08% median: -4.00% win: 40% σ: 6.06% n: 5 2022-04-12 → 2026-05-29 | JAZZ May avg: -2.28% median: -6.58% win: 20% σ: 10.59% n: 5 2022-04-12 → 2026-05-29 | JAZZ Jun avg: 0.14% median: -0.20% win: 50% σ: 3.35% n: 4 2022-04-12 → 2026-05-29 (current) | JAZZ Jul avg: 4.14% median: 4.25% win: 100% σ: 3.36% n: 4 2022-04-12 → 2026-05-29 | JAZZ Aug avg: 6.51% median: 7.56% win: 75% σ: 5.40% n: 4 2022-04-12 → 2026-05-29 | JAZZ Sep avg: -6.15% median: -6.83% win: 25% σ: 7.49% n: 4 2022-04-12 → 2026-05-29 | JAZZ Oct avg: 2.30% median: 1.60% win: 50% σ: 4.67% n: 4 2022-04-12 → 2026-05-29 | JAZZ Nov avg: 10.24% median: 9.81% win: 75% σ: 14.38% n: 4 2022-04-12 → 2026-05-29 | JAZZ Dec avg: 0.79% median: 1.41% win: 75% σ: 3.24% n: 4 2022-04-12 → 2026-05-29 |